Welcome to our dedicated page for Altria Group news (Ticker: MO), a resource for investors and traders seeking the latest updates and insights on Altria Group stock.
Altria Group, Inc. (MO) generates a steady flow of news through its financial results, product updates, capital allocation decisions and corporate governance actions. As a U.S. tobacco manufacturing company with both combustible and smoke-free products, Altria regularly issues press releases and files current reports that provide insight into its operations, portfolio and strategic direction.
Investors following MO news can expect detailed earnings announcements covering quarterly and year-to-date performance, including net revenues, earnings per share metrics and commentary on segment trends in smokeable and oral tobacco products. These releases often discuss factors affecting results, such as pricing, volume, special items, and the performance of brands like on! within the oral tobacco segment.
Altria’s news flow also highlights capital returns and financing activity. The company frequently announces regular quarterly dividends and dividend increases, as well as share repurchase activity and changes to its share repurchase program authorization. In addition, it discloses debt offerings and related agreements through press releases and Form 8-K filings, outlining new senior unsecured notes and credit facility amendments.
Corporate and strategic developments are another key news category. Altria reports on leadership and Board changes, including CEO succession plans, future appointments to executive roles and the planned retirement of directors. It also issues updates on its smoke-free strategy, such as product launches in oral nicotine pouches, regulatory submissions for heated tobacco sticks and collaboration agreements, including its memorandum of understanding with KT&G Corporation for modern oral and non-nicotine opportunities.
This MO news page helps readers track these disclosures in one place, from dividend declarations and webcast announcements to strategic partnerships and regulatory milestones. Regular review of Altria’s news can provide context for the company’s financial performance, portfolio evolution and governance decisions.
Summary not available.
Summary not available.
Summary not available.
Altria Group, Inc. (NYSE: MO) reported first-quarter 2023 results, demonstrating a 5.4% increase in adjusted diluted EPS to $1.18, while net revenues decreased by 2.9% to $5,719 million. The company reaffirmed its full-year adjusted diluted EPS guidance of $4.98 to $5.13, reflecting a growth rate of 3% to 6% from 2022. Despite facing challenges from high inflation impacting adult tobacco consumer behaviors and a decline in cigarette volumes, Altria maintained brand loyalty in its tobacco segment. Additionally, Altria announced plans to complete a $2.75 billion acquisition of NJOY and has retired $1.3 billion of debt in early 2023.
The company also highlighted its commitment to sustainability with goals such as achieving 100% renewable electricity by 2030.
A recent survey from Altria (NYSE: MO) indicates strong support for tobacco harm reduction strategies among American adults. Approximately 66% of participants advocate for the FDA to prioritize harm reduction instead of prohibition, believing it essential for adult smokers to access smoke-free alternatives. Notably, 90% of respondents feel the FDA should inform consumers about the risks of different tobacco products, and 84% believe prohibition would spawn illicit markets, potentially compromising public health. The survey found support among primary care physicians and policy professionals, with 89% and 78% respectively backing harm reduction as a more effective regulatory strategy. Overall, the findings stress the public’s desire for a regulated, informed approach to tobacco usage, which could significantly impact Altria's future business strategy.
Altria Group, Inc. (NYSE: MO) will host a live audio webcast on April 27, 2023, at 9:00 a.m. ET to discuss its 2023 first-quarter business results. A press release with the results will be available at approximately 7:00 a.m. ET on the same day. The webcast will feature CEO Billy Gifford and CFO Sal Mancuso discussing the results and addressing questions from investors and media. The event requires pre-event registration, and an archived version will be accessible on altria.com following the live session.
Altria Group hosted an investor day conference in New York, detailing its 2028 Enterprise Goals for financial metrics and smoke-free product growth. Key aims include achieving mid-single digit growth in adjusted diluted EPS by 2028 and doubling smoke-free net revenues to $5 billion by growing volumes by at least 35% from 2022 levels. The company reaffirmed its 2023 full-year adjusted diluted EPS guidance of $4.98 to $5.13, reflecting 3% to 6% growth from 2022. Altria's internal product development updates included new smoke-free innovations like SWIC and on! PLUS, with regulatory applications yet to be filed.
Altria Group will host a live webcast of its Investor Day on March 23, 2023, in New York, NY. The event will start at 9:00 a.m. and conclude around 12:30 p.m. Eastern Time. Presentations will be led by Billy Gifford, Altria's CEO, alongside key leadership members. This webcast is available in listen-only mode, and registration is required in advance. Interested participants can find registration details at www.altria.com/webcasts. An archived version of the presentation will be accessible on Altria's website after the event.
Altria Group, Inc. (NYSE: MO) announced a definitive agreement to acquire NJOY Holdings, Inc., a significant move in the company's strategy to enhance its portfolio in the tobacco industry. The announcement was made via a press release at 7:00 a.m. ET on March 6, 2023, followed by a live webcast at 9:00 a.m. ET to discuss the acquisition details. CEO Billy Gifford will lead the discussion, aimed at addressing investor queries. The webcast can be accessed at altria.com.
Altria Group has announced a definitive agreement to acquire NJOY Holdings for about $2.75 billion in cash. The deal includes up to $500 million in contingent payments based on regulatory approvals of certain NJOY products. NJOY’s e-vapor product, NJOY ACE, is the only pod-based e-vapor product authorized by the FDA. Altria aims to leverage its extensive commercial resources to bolster NJOY's market presence, enhancing its smoke-free product portfolio. This acquisition is poised to be accretive to cash flow within two years and improve adjusted diluted EPS within three years.